Consytel Life Sciences

Hyderabad, India Founded: 2017 • Age: 9 yrs
Nature-derived malaria products are manufactured for immune health support.
Annual revenue $35,127 Latest available
Total funding $44,282 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Consytel Life Sciences

Consytel Life Sciences is a company based in Hyderabad (India) founded in 2017 by Shubhendu Kumar Dash. Consytel Life Sciences has raised $44.28 thousand across 1 funding round from investors including AIC-CCMB.

  • Headquarter Hyderabad, India
  • Founders Shubhendu Kumar Dash
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Consytel Life Sciences Private Limited
  • Date of Incorporation 22 Dec, 2017
  • Jurisdiction Secunderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $35.13 K (USD)
    6.37
    as on Mar 31, 2022
  • Net Profit
    $737.96 (USD)
    10.91
    as on Mar 31, 2022
  • EBITDA
    $2.06 K (USD)
    11.63
    as on Mar 31, 2022
  • Total Equity Funding
    $44.28 K (USD)

    in 1 rounds

  • Latest Funding Round
    $44.28 K (USD), Seed

    Jan 16, 2026

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Consytel Life Sciences

Consytel Life Sciences has successfully raised a total of $44.28K through 1 strategic funding round. The most recent funding activity was a Seed round of $44.28 thousand completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Consytel Life Sciences

Consytel Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include AIC-CCMB.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Premium access

Investor details for Consytel Life Sciences

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Consytel Life Sciences

Investments
Premium access

Investment portfolio details for Consytel Life Sciences

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Consytel Life Sciences

Premium access

Detailed financials for Consytel Life Sciences

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Consytel Life Sciences Comparisons

Consytel Life Sciences Primary company
Description
Nature-derived malaria products are manufactured for immune ...
Location
Hyderabad, India
Founded Year
2017
Annual Revenue
$35.13 K (USD)
Net Profit
$737.96 (USD)
EBITDA
$2.06 K (USD)
Employees
Not available
Premium access

Peer comparison for Consytel Life Sciences

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Consytel Life Sciences

Premium access

Detailed competitors of Consytel Life Sciences

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Consytel Life Sciences

Premium access

Complete news archive for Consytel Life Sciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Consytel Life Sciences

Consytel Life Sciences was founded in 2017 and raised its 1st funding round 9 years after it was founded.

Consytel Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Consytel Life Sciences is a funded company, having raised a total of $44.28K across 1 funding round to date.

Annual revenue of Consytel Life Sciences is $35.13K as on Mar 31, 2022.

Consytel Life Sciences was founded in 2017 and is based in Hyderabad, India. Operations focus on the life sciences sector, where nature-derived products for malaria treatment are produced. Emphasis is placed on supporting immune system function for overall human health maintenance. Manufacturing processes are centered on natural ingredients, with activities conducted primarily in the Indian pharmaceutical landscape.

Consytel Life Sciences has 1 investor. Key investors include AIC-CCMB.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available